MetVital, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Trial of AEO in New Glioblastoma (GBM)
Phase 2
- Conditions
- Glioblastoma Multiforme
- Interventions
- Other: Standard of CareDrug: Anhydrous Enol-Oxaloacetate (AEO)
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- MetVital, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04450160
News
No news found